Modified AutoDock for accurate docking of protein kinase inhibitors

被引:51
作者
Buzko, OV [1 ]
Bishop, AC [1 ]
Shokat, KM [1 ]
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
关键词
approximation of solvation; AutoDock; force field; hydrogen bonding; inhibitor design; scoring function;
D O I
10.1023/A:1016366013656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases are an important class of enzymes controlling virtually all cellular signaling pathways. Consequently, selective inhibitors of protein kinases have attracted significant interest as potential new drugs for many diseases. Computational methods, including molecular docking, have increasingly been used in the inhibitor design process [1]. We have considered several docking packages in order to strengthen our kinase inhibitor work with computational capabilities. In our experience, AutoDock offered a reasonable combination of accuracy and speed, as opposed to methods that specialize either in fast database searches or detailed and computationally intensive calculations. However, AutoDock did not perform well in cases where extensive hydrophobic contacts were involved, such as docking of SB203580 to its target protein kinase p38. Another shortcoming was a hydrogen bonding energy function, which underestimated the attraction component and, thus, did not allow for sufficiently accurate modeling of the key hydrogen bonds in the kinase-inhibitor complexes. We have modified the parameter set used to model hydrogen bonds, which increased the accuracy of AutoDock and appeared to be generally applicable to many kinase-inhibitor pairs without customization. Binding to largely hydrophobic sites, such as the active site of p38, was significantly improved by introducing a correction factor selectively affecting only carbon and hydrogen energy grids, thus, providing an effective, although approximate, treatment of solvation.
引用
收藏
页码:113 / 127
页数:15
相关论文
共 63 条
[1]  
AJAY MMA, 1995, J MED CHEM, V38, P4953
[2]   MOLECULAR MECHANICS - THE MM3 FORCE-FIELD FOR HYDROCARBONS .1. [J].
ALLINGER, NL ;
YUH, YH ;
LII, JH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (23) :8551-8566
[3]   Type I Receptor Tyrosine Kinases as Targets for Therapy in Breast Cancer [J].
Baselga, Jose ;
Mendelsohn, John .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1997, 2 (02) :165-174
[4]   Generalized born models of macromolecular solvation effects [J].
Bashford, D ;
Case, DA .
ANNUAL REVIEW OF PHYSICAL CHEMISTRY, 2000, 51 :129-152
[5]   New approach to molecular docking and its application to virtual screening of chemical databases [J].
Baxter, CA ;
Murray, CW ;
Waszkowycz, B ;
Li, J ;
Sykes, RA ;
Bone, RGA ;
Perkins, TDJ ;
Wylie, W .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (02) :254-262
[6]   Unnatural ligands for engineered proteins: New tools for chemical genetics [J].
Bishop, A ;
Buzko, O ;
Heyeck-Dumas, S ;
Jung, I ;
Kraybill, B ;
Liu, Y ;
Shah, K ;
Ulrich, S ;
Witucki, L ;
Yang, F ;
Zhang, C ;
Shokat, KM .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2000, 29 :577-606
[7]   Acquisition of inhibitor-sensitive protein kinases through protein design [J].
Bishop, AC ;
Shokat, KM .
PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) :337-346
[8]   A chemical switch for inhibitor-sensitive alleles of any protein kinase [J].
Bishop, AC ;
Ubersax, JA ;
Petsch, DT ;
Matheos, DP ;
Gray, NS ;
Blethrow, J ;
Shimizu, E ;
Tsien, JZ ;
Schultz, PG ;
Rose, MD ;
Wood, JL ;
Morgan, DO ;
Shokat, KM .
NATURE, 2000, 407 (6802) :395-401
[9]   Design of allele-specific inhibitors to probe protein kinase signaling [J].
Bishop, AC ;
Shah, K ;
Liu, Y ;
Witucki, L ;
Kung, CY ;
Shokat, KM .
CURRENT BIOLOGY, 1998, 8 (05) :257-266
[10]   Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach [J].
Bishop, AC ;
Kung, CY ;
Shah, K ;
Witucki, L ;
Shokat, KM ;
Liu, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (04) :627-631